Oncolytics Biotech Q3 Results Scheduled for October 30
The company is expected to report Q3'26 results on October 30. Revenue is estimated at 0 USD and EPS at (0.05) USD; the release time is not specified.
Oncolytics Biotech Inc. (ONCY) is scheduled to report its Q3'26 results on October 30. The release time has not been specified, though the results are expected at 8:00 AM ET (12:00 PM UTC). For Q3'26, revenue is estimated at 0 USD, while EPS (earnings per share) is expected to be (0.05) USD.